Medicines optimisation

Medicines play an important part in promoting wellbeing, preventing ill health and managing disease. More than 700million prescription items are dispensed in England each year with a cost approaching £8billion.

Medicines management can be defined in several ways:

  • The clinical, cost-effective, safe and secure handling of medicines.
  • A system of processes and behaviours that determines how medicines are used by the NHS and patients.
  • Enabling people to make the best possible use of medicines.

Our goal is to achieve the best health outcomes for patients where medicines are involved.

Many decisions relating to medicines management on the Fylde Coast are made on a Lancashire and South Cumbria-wide basis by the Lancashire and South Cumbria Medicines Management Group (LSCMMG).

Further information on medicine guidelines, prescribing guidance, position statements and supporting documents, shared care guidelines and high-cost medicines can be found on the LSCMMG website.

CLICK HERE FOR LSCMMG

Click each header to expand its content

Fylde Coast medicines RAG list

Blood and nutrition

Cardiovascular system

Ear, nose and oropharynx

Endocrine system

Eye

Gastro-intestinal system

Musculoskeletal system

Arthritis

DMARDs

Shared care drugs included in GP Enhanced contract scheme

Shared care drugs not included in GP Enhanced contract scheme

Other MSK

Nervous system (pain management and psychotics)

Respiratory system

Asthma

COPD

Inhaler techniques

E-cigarettes

Skin

Miscellaneous

Prescribing process

Other policies

Rebate policies

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third-party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Fylde & Wyre Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – commenced July 2019
  • Dabigatran (Pradaxa) – commenced November 2020
  • Degarelix (Firmagon) – commenced September 2016
  • Fostair NEXThaler – commenced May 2021
  • Fostair pMDI – commenced July 2021
  • Fencino (Fentanyl) – commenced April 2016
  • Longtec – commenced July 2019
  • Prostap (Leuprorelin) – commenced April 2020
  • Rivaroxaban (Xarelto) – commenced October 2019
  • Sereflo – commenced July 2019
  • Toujeo (Insulin Glargine) – commenced July 2021
  • Zacco (Clobazam) – commenced March 2021
  • Zoladex (Goserelin) commenced January 2019

Blackpool Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – commenced July 2019
  • Dabigatran (Pradaxa) – commenced November 2020
  • Degarelix (Firmagon) – commenced September 2016
  • Fostair NEXThaler – commenced May 2021
  • Fostair pMDI – commenced July 2021
  • Fencino (Fentanyl) – commenced October 2018
  • Longtec – commenced July 2019
  • Prostap (Leuprorelin) – commenced April 2020
  • Rivaroxaban (Xarelto) – commenced July 2019
  • Sereflo – commenced July 2019
  • Toujeo (Insulin Glargine) – commenced July 2021
  • Zacco (Clobazam) – commenced March 2021
  • Zoladex (Goserelin) commenced July 2019

Care homes

BLACKPOOL ONLY: Shared care drugs included in GP enhanced contract scheme

If you can’t find what you are looking for and think it was once listed in these pages, try the LSCMMG or our files archive

Last updated on 4 January 2022 at 12:18 by senior communications and engagement officer